Di Yu

Professor Di Yu is a Chair in Paediatric Immunotherapy, Professor of Immunology, Director of Ian Frazer Centre of Children's Immunotherapy Research, and Head of Systems and Translational T-cell Immunology Laboratory (STTIL) at the University of Queensland. He earned his PhD from the Australian National University in 2007 and postdoctoral training at the Garvan Institute of Medical Research from 2008-2010. Before joining the University of Queensland, he was a faculty member at Monash University from 2011-2016 and at the Australian National University ANU from 2017-2019. His research focuses on exploring T cell subsets and developing new therapies to regulate their functions in clinical settings, with the goal of treating autoimmune diseases and cancer. He also leads the development and application of "systems immunology" techniques to evaluate individuals' immune status. Professor Yu has authored over 100 publications of basic and translational research in immunology, including Nature, Nature Immunology, Nature Medicine, Immunity and Science Immunology, and is a Clarivate Highly Cited Researcher. In recognising his groundbreaking research, he has been elected as a Fellow of the Australian Academy of Health and Medical Sciences (FAHMS) and honoured with accolades such as the 2023 Jacques Miller Medal from the Australian Academy of Science (AAS), the 2021 Jian Zhou Medal from the Australian Academy of Health and Medical Sciences (AAHMS), and the inaugural 2021 AbbVie New Horizon Research Award from the Australia and New Zealand Society for Immunology (ASI), among others. T cell subsets and developing new therapies to regulate their functions in clinical settings, with the goal of treating autoimmune diseases and cancer; systems immunology techniques to evaluate individuals' immune status

[2026] Targeting T follicular helper cells for lifelong health. Linterman, Michelle A., Yu, Di, Webb, Louise M. C. and Vinuesa, Carola G. (2026). Nature Reviews Drug Discovery, 1-13. doi: 10.1038/s41573-026-01495-3 [2026] Neuritin's potential as a new therapeutic target for diverse autoimmune diseases. Zeng, Wen, Yu, Di and Canete, Pablo F. (2026). Molecular Therapy, 34 (8), 4379-4381. doi: 10.1016/j.ymthe.2026.07.014 [2026] Animal models of allergen immunotherapy for allergic airway inflammation. Zhang, Fang, Sun, Shi-ran, Wu, Xing-liang, Ma, Jing-yi, Yu, Di, Liu, Zheng and Yao, Yin (2026). Allergy, 81 (5), 1433-1458. doi: 10.1111/all.70323 [2026] Modulation of the mevalonate pathway by TCR engagement regulates T follicular helper cell generation in homeostasis and autoimmunity. Wang, Lai